Donald M. Lloyd-Jones, MD, MS

Donald M. Lloyd-Jones, MD, MS, is a board-certified cardiologist and epidemiologic researcher at Boston Medical Center (BMC), where he serves as Chief of the Section of Preventive Medicine within the Department of Medicine. He is also a Professor of Medicine at the Boston University Chobanian & Avedisian School of Medicine. As of January 2025, Dr. Lloyd-Jones directs the Framingham Center for Population and Prevention Science, which runs the multidecade Framingham Heart Study.

Dr. Lloyd-Jones received his medical degree from Columbia University in New York, New York. He completed his internal medicine residency followed by a fellowship in cardiovascular medicine at Massachusetts General Hospital in Boston. He additionally holds a master of science degree (ScM) in epidemiology from the Harvard T.H. Chan School of Public Health in Boston.

Dr. Lloyd-Jones' research interests include the study of the mechanisms and life course of cardiovascular health and healthy aging, and cardiovascular disease epidemiology, risk estimation and prevention. Other areas of interest include the use of novel biomarkers and imaging of subclinical atherosclerosis to improve prevention, and the epidemiology and outcomes of hypertension and dyslipidemia.

He also has been a national leader in public health and clinical approaches to promoting cardiovascular health and preventing cardiovascular diseases across the life course. He served as co-chair of the Risk Assessment Guidelines and a member of the Cholesterol Treatment Guidelines Panel for the 2013 ACC/AHA Guidelines for Cardiovascular Disease Risk Reduction and was the lead member for risk assessment on the 2018 Cholesterol Guidelines Panel and the 2019 Primary Prevention Guidelines Panel. He has authored over 750 peer-reviewed scientific publications and has been a PI or co-investigator on more than 120 grants (the vast majority from NIH).

Dr. Lloyd-Jones’ clinical interests lie in general cardiology, with a focus on prevention.